Skip to main content
. 2017 Nov 22;12:8389–8410. doi: 10.2147/IJN.S147355

Figure 10.

Figure 10

The clinical photographs of the mouse treated with MHAp on magnetic field exposure. The tumor on (A) day 1, (B) day 5, and (C) day 14 is shown. Reprinted from Hou CH, Hou SM, Hsueh YS, Lin J, Wu HC, Lin FH. The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy. Biomaterials. 2009;30(23–24):3956–3960. Copyright 2009, with permission from Elsevier.69

Abbreviation: MHAp, magnetic hydroxyapatite.